Aquracy Therapeutics is a R&I company committed to find and potentiate new gene therapies for life-threatening genetic diseases. Determined to develop and translate innovative therapies to the clinical setting, Aquracy Therapeutics is highly specialized in pre-clinical research offering state-of-art services and scientific consultancy in the field of gene therapy.
Research, development and innovation in biotechnology at Aquracy Therapeutics (aquracytherapeutics@gmail.com)
Company Details
- Employees
- 2
- Address
- Campus De Gambelas, Pavilhão B1, Faro,portugal
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- Gene Therapy, Neurodegenerative Diseases, Disease Models, Viral Vectors, Scientific Writing, Pre-clinical Design & Setting, Scientific Consultancy, Rare Diseases, Polyglutamine Diseases, Bioinformatic Tools.
- HQ
- Faro
Aquracy Therapeutics Questions
Aquracy Therapeutics's LinkedIn profile is https://pt.linkedin.com/company/aquracy-therapeutics
Aquracy Therapeutics has
2 employees.
View email and phone details for 2
employees at Aquracy Therapeutics.
Aquracy Therapeutics's industry is
Biotechnology Research
Aquracy Therapeutics's top competitors are
Eclipsia,
Colab Trials,
P-Bio - Associação Portuguesa De Bioindústria,
Taguspark,
Solfarcos -Soluções Farmacêuticas E Cosméticas, Lda.,
Omniumai,
Medgical,
Lxbio Pharmaceuticals,
Agrogrin Tech,
Bac3gel.
Aquracy Therapeutics's categories are Biotechnology Research
